Our Pricing

Mounjaro Selby: Expert Guide to Accessing Tirzepatide Weight Loss Treatment

Published: 2 October 2026

Mounjaro Selby residents now have direct access to tirzepatide weight loss injections through Cured Pharmacy, a fully UK-registered online service offering genuine licensed medication from £124.99. As a GPhC-registered pharmacy (9012511) led by superintendent pharmacist Tarun Kumar (GPhC 2233073), we provide Selby patients with the same clinical rigour and regulatory standards as high-street pharmacies, combined with transparent pricing and discreet home delivery. All Mounjaro prescriptions require online assessment by our UK-registered prescribers, ensuring safe, personalised treatment for eligible patients across North Yorkshire.

What Is Mounjaro and Why Selby Residents Are Choosing It

Mounjaro Selby enquiries have surged following the medication's MHRA approval in November 2023 for chronic weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities [1]. The active ingredient, tirzepatide, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist—the first in its class—offering a novel mechanism that clinical trials suggest may deliver superior weight reduction compared to single-pathway GLP-1 agonists.

In the landmark SURMOUNT-1 trial, participants using the 15mg maintenance dose of tirzepatide achieved an average weight loss of 20.9% over 72 weeks, significantly outperforming placebo groups [2]. For Selby patients managing obesity alongside conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea, Mounjaro represents a clinically validated option that addresses both metabolic dysfunction and cardiovascular risk factors. Our Selby-based patients appreciate the convenience of online consultations combined with next-day delivery across North Yorkshire, eliminating the need for repeated in-person GP visits.

How to Access Mounjaro in Selby Through Cured Pharmacy

Accessing Mounjaro Selby services via Cured Pharmacy involves a straightforward three-step process designed to meet all UK regulatory requirements. First, complete our free online medical questionnaire (typically under three minutes), providing details about your weight history, current BMI, existing health conditions, and any medications you currently take. Our UK-registered prescribers review every submission individually, ensuring Mounjaro is clinically appropriate and safe for your circumstances.

Once approved, your prescription is dispensed by our GPhC-registered pharmacy team and dispatched in fully discreet packaging via next-day courier to any Selby address. We source all Mounjaro stock directly from UK-licensed wholesalers, guaranteeing authenticity and full cold-chain compliance for this temperature-sensitive injectable. Patients in Selby benefit from transparent upfront pricing—£124.99 per four-week supply at starter doses—with no hidden consultation fees or membership charges.

Mounjaro Selby Eligibility Criteria

To qualify for Mounjaro Selby prescriptions, you must meet MHRA-approved criteria: a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, dyslipidaemia, or obstructive sleep apnoea [1]. You must be aged 18 or over, and not pregnant, breastfeeding, or planning pregnancy. Our prescribers will also assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. If Mounjaro is deemed unsuitable, our clinical team may recommend alternative treatments such as Wegovy (semaglutide) or Saxenda (liraglutide), both available through the same streamlined consultation process.

Mounjaro Selby Dosing Schedule and What to Expect

Mounjaro Selby patients follow a structured dose-escalation protocol designed to minimise gastrointestinal side effects while optimising weight loss outcomes. Treatment begins with a 2.5mg subcutaneous injection once weekly for four weeks, serving as an initiation dose rather than a therapeutic dose. After this initial phase, the dose increases to 5mg weekly for four weeks, then 7.5mg, 10mg, 12.5mg, and finally 15mg at four-week intervals, depending on individual tolerance and response [2].

Most patients achieve clinically significant weight loss (≥5% body weight) within 12–16 weeks, with peak efficacy observed at the 10mg or 15mg maintenance doses. During titration, our Selby patients report manageable nausea and reduced appetite as the most common side effects, typically diminishing after the first few weeks at each new dose. We provide detailed injection technique guidance and ongoing support via our pharmacist helpline, ensuring you feel confident administering Mounjaro at home.

Mounjaro Selby Injection Technique and Storage

Each Mounjaro KwikPen is a single-patient-use, pre-filled injection device delivering one weekly dose subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites each week to reduce the risk of lipodystrophy. Store unused pens in the refrigerator at 2–8°C, and never freeze. Once in use, a pen may be kept at room temperature (up to 30°C) for up to 21 days. Our Selby deliveries include insulated packaging with gel packs to maintain cold-chain integrity during transit, even in warmer months.

Mounjaro Selby Pricing and How We Keep Costs Transparent

Mounjaro Selby pricing at Cured Pharmacy starts from £124.99 per four-week supply (one pen), with the exact cost depending on your prescribed dose. Unlike some online providers, we display all prices upfront—before you begin the consultation—so there are no surprises at checkout. First-time customers receive £20 off their initial order using code Weightlossnew, reducing the starting price to £124.99.

We recognise that weight management is a long-term commitment, often requiring 6–12 months of continuous treatment to achieve and maintain clinically meaningful results. Our pricing structure reflects competitive UK market rates while ensuring every pen is sourced from MHRA-approved suppliers and dispensed under the oversight of our superintendent pharmacist. For Selby residents comparing options, our transparent model eliminates the guesswork and hidden fees that can inflate costs elsewhere.

Clinical Evidence Supporting Mounjaro for Selby Patients

The efficacy of Mounjaro Selby prescriptions is underpinned by robust phase 3 trial data from the SURMOUNT programme. SURMOUNT-1 enrolled 2,539 adults with obesity (without diabetes) and demonstrated that tirzepatide 15mg resulted in an average 20.9% reduction in body weight over 72 weeks, compared to 3.1% with placebo [2]. Importantly, 91% of participants on the highest dose achieved ≥5% weight loss, and 57% achieved ≥20% weight loss—outcomes rarely seen with lifestyle interventions alone.

SURMOUNT-2, which included participants with type 2 diabetes, showed similar efficacy alongside meaningful improvements in glycaemic control, with HbA1c reductions of up to 2.1% [3]. For Selby patients managing both obesity and metabolic syndrome, these dual benefits make Mounjaro a compelling choice. Secondary endpoints across the SURMOUNT trials also revealed improvements in waist circumference, blood pressure, lipid profiles, and inflammatory markers, underscoring tirzepatide's systemic metabolic effects [2][3].

Mounjaro Selby Safety Profile and Side Effects

The most frequently reported side effects in Mounjaro Selby users mirror those observed in clinical trials: nausea (reported in up to 33% of participants), diarrhoea, vomiting, constipation, and abdominal discomfort [2]. These gastrointestinal symptoms are typically mild to moderate, transient, and diminish with continued use and dose titration. Rare but serious risks include pancreatitis, gallbladder disease, and hypoglycaemia (particularly when used alongside insulin or sulphonylureas). Our prescribers conduct thorough risk assessments during consultations to identify patients at higher risk and provide tailored safety advice.

Why Choose Cured Pharmacy for Mounjaro Selby Services

Cured Pharmacy distinguishes itself through a combination of regulatory compliance, clinical expertise, and patient-centred service tailored to Mounjaro Selby demand. As a GPhC-registered pharmacy (9012511) with a dedicated superintendent pharmacist, we adhere to the same stringent standards as high-street pharmacies, including full traceability of medicines, secure data handling, and ongoing professional oversight. Every prescription is reviewed by UK-registered prescribers with specialist training in obesity medicine and metabolic health.

Our Selby patients benefit from discreet next-day delivery, transparent pricing with no hidden fees, and a pharmacist support line available throughout treatment. We also offer flexible follow-up consultations to adjust doses, manage side effects, or switch treatments if needed. Unlike some online-only providers, we prioritise continuity of care, ensuring you receive the same level of clinical attention and accountability you would expect from a traditional pharmacy. For Selby residents seeking a trusted partner in their weight loss journey, Cured Pharmacy combines convenience with uncompromising quality and safety.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 2 October 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038 [accessed 2 October 2026]
3. Garvey, W. T., Frias, J. P., Jastreboff, A. M., le Roux, C. W., Sattar, N., Aizenberg, D., ... & Davies, M. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X [accessed 2 October 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 2 October 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 2 October 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 2 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.